Integer (NYSE:ITGR) Price Target Raised to $140.00

Integer (NYSE:ITGR) had its target price raised by Benchmark from $130.00 to $140.00 in a research note published on Monday morning, Benzinga reports. The firm currently has a buy rating on the medical equipment provider’s stock.

Other research analysts have also issued research reports about the stock. Truist Financial upped their price target on shares of Integer from $145.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Citigroup raised their price target on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. Oppenheimer assumed coverage on shares of Integer in a report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price objective on the stock. Bank of America boosted their target price on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday, October 1st. Finally, KeyCorp increased their price target on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 15th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Integer presently has an average rating of “Moderate Buy” and a consensus price target of $140.14.

Integer Stock Up 0.8 %

Shares of ITGR stock opened at $126.53 on Monday. The stock’s fifty day moving average price is $127.37 and its 200 day moving average price is $120.86. Integer has a 1-year low of $69.40 and a 1-year high of $133.53. The company has a market cap of $4.24 billion, a price-to-earnings ratio of 43.78, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.06. The firm had revenue of $436.20 million for the quarter, compared to the consensus estimate of $437.00 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The company’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.14 earnings per share. On average, research analysts expect that Integer will post 5.3 earnings per share for the current fiscal year.

Insider Activity

In other Integer news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the transaction, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integer

Several large investors have recently bought and sold shares of the company. Contravisory Investment Management Inc. lifted its stake in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 80 shares in the last quarter. Xponance Inc. lifted its stake in Integer by 4.9% in the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock worth $245,000 after purchasing an additional 99 shares in the last quarter. Azzad Asset Management Inc. ADV grew its position in shares of Integer by 0.9% in the third quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock valued at $1,504,000 after purchasing an additional 107 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Integer by 60.9% in the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after purchasing an additional 142 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. lifted its position in Integer by 3.6% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock worth $689,000 after buying an additional 205 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.